Latest Breaking News On - Arcturus therapeutics holdings - Page 1 : comparemela.com

Arcturus Therapeutics Announces Positive Development for Cystic Fibrosis Program

Arcturus to present new Phase 1b interim data for ARCT-032 at European Cystic Fibrosis Conference on June 7, 2024 First four CF patients demonstrated an average improvement of 4% FEV1 after two.

United kingdomUnited statesSan diegoJoseph payneJuergen froehlichDrug administrationMrna technologyArcturus therapeutics holdings incEuropean medicines agencyArcturus therapeutics holdingsEuropean cystic fibrosis conferenceForced expiratory volumeChief medical officerOrphan medicinal product designationOrphan drug designationPrivate securities litigation reform act

Arcturus Therapeutics Holdings Inc Announces Positive Development for Cystic Fibrosis Program

Arcturus Therapeutics Holdings Inc. announced ARCT-032 will be presenting Phase 1 results in healthy volunteers and new Phase 1b interim data in CF patients for ARCT-032, an inhaled investigational.

European medicines agencyDrug administrationArcturus therapeutics holdings incArcturus therapeutics holdingsEuropean cystic fibrosis conferenceOrphan medicinal product designationOrphan drug designation

Why Is Arcturus Therapeutics Stock Trading Higher On Tuesday?

Why Is Arcturus Therapeutics Stock Trading Higher On Tuesday?
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Arcturus therapeutics holdings incArcturus therapeutics holdingsEuropean cystic fibrosis

Why Is Arcturus Therapeutics Stock Trading Higher On Tuesday? - Arcturus Therapeutics (NASDAQ:ARCT)

Arcturus Therapeutics' early Phase 1 results show ARCT-032 is safe and well-tolerated, with promising improvements in lung function.

Juergen froehlichJoseph payneWilliam blairVertex pharmaceuticals incorporatedArcturus therapeutics holdings incArcturus therapeutics holdingsCystic fibrosisForced expiratory volumeChief medical officer

Arcturus Therapeutics (NASDAQ:ARCT) Trading 5 8% Higher

Arcturus Therapeutics (NASDAQ:ARCT) Trading 5 8% Higher
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

William blairKokusai asset management coBarclays plcYork mellon corpMitsubishi ufjCommonwealth equity servicesArcturus therapeutics holdings incCanaccord genuity groupArcturus therapeutics company profileArcturus therapeutics holdingsGet free reportArcturus therapeuticsEquity servicesNew york mellon corpAsset managementTherapeutics holdings inc